tiprankstipranks
Trending News
More News >
BICO Group AB Class B (CLLKF)
OTHER OTC:CLLKF

BICO Group AB Class B (CLLKF) Price & Analysis

Compare
34 Followers

CLLKF Stock Chart & Stats

$1.98
$0.10(3.47%)
At close: 4:00 PM EST
$1.98
$0.10(3.47%)

BICO Group AB Class B News

CLLKF FAQ

What was BICO Group AB Class B’s price range in the past 12 months?
BICO Group AB Class B lowest stock price was $1.76 and its highest was $4.33 in the past 12 months.
    What is BICO Group AB Class B’s market cap?
    BICO Group AB Class B’s market cap is $138.10M.
      When is BICO Group AB Class B’s upcoming earnings report date?
      BICO Group AB Class B’s upcoming earnings report date is Feb 18, 2026 which is in 60 days.
        How were BICO Group AB Class B’s earnings last quarter?
        BICO Group AB Class B released its earnings results on Nov 04, 2025. The company reported -$1.695 earnings per share for the quarter, missing the consensus estimate of -$0.11 by -$1.585.
          Is BICO Group AB Class B overvalued?
          According to Wall Street analysts BICO Group AB Class B’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does BICO Group AB Class B pay dividends?
            BICO Group AB Class B does not currently pay dividends.
            What is BICO Group AB Class B’s EPS estimate?
            BICO Group AB Class B’s EPS estimate is -0.05.
              How many shares outstanding does BICO Group AB Class B have?
              BICO Group AB Class B has 69,074,900 shares outstanding.
                What happened to BICO Group AB Class B’s price movement after its last earnings report?
                BICO Group AB Class B reported an EPS of -$1.695 in its last earnings report, missing expectations of -$0.11. Following the earnings report the stock price went down -1.172%.
                  Which hedge fund is a major shareholder of BICO Group AB Class B?
                  Currently, no hedge funds are holding shares in CLLKF
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    BICO Group AB Class B

                    BICO Group AB (publ) operates as a bio convergence company in North America, Europe, Asia, and internationally. It operates through two segments, Laboratory Solutions and Bioautomation. The Laboratory Solutions segment offers 3D bioprinters, hybrid microscopes, single-cell dispensing instruments, and liquid handling instruments, as well as services and related consumables, such as bioinks, reagents, microscope lenses, software, printheads, and 3D reconstructed human tissues for applications in regulatory testing. This segment also offers services in 3D cell culture, 3D tissue imaging, multiplex imaging, and digital pathology to pharmaceutical and biotechnology companies. The Bioautomation segment offers products in precision dispensing and biosensor technology to the industrial customer; and diagnostics automation and advanced robotics solutions for the medical and diagnostic industries. In addition, it offers core industrial ecosystem, tissue engineering, multi-omics, cell line development, and diagnostics solutions. It primarily serves medical, pharmaceutical, and cosmetic industries. The company was formerly known as Cellink AB (publ) and changed its name to BICO Group AB (publ) in August 2021. BICO Group AB (publ) was founded in 2016 and is based in Gothenburg, Sweden.

                    BICO Group AB Class B (CLLKF) Earnings & Revenues

                    CLLKF Company Deck

                    CLLKF Earnings Call

                    Q3 2025
                    0:00 / 0:00
                    Earnings Call Sentiment|Neutral
                    The earnings call presents a mixed picture with strong growth in Lab Automation and significant orders from a global pharma company. However, impairments and macroeconomic challenges, including negative cash flow from operations, present notable challenges.View all CLLKF earnings summaries
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    CellaVision AB
                    Senzime AB
                    Bactiguard Holding AB
                    C-Rad AB Class B
                    Sedana Medical AB

                    Ownership Overview

                    0.02%1.56%96.20%
                    Insiders
                    1.56% Other Institutional Investors
                    96.20% Public Companies and
                    Individual Investors

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks